Zadek osteotomy to treat Haglund's heel deformity.
Official title: Zadek Osteotomy for Treatment of Haglund's Syndrome
Run by Sohag University · NCT07157319 · Data updated 2026-11-12
This project will try Zadek osteotomy surgery to relieve heel pain and improve function in adults aged 18–60 with Haglund's syndrome who have not improved after at least six months of conservative care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | October 2025 |
| Study ends | December 2025 |
| Registry record updated | September 5, 2025 |
| Trial ID | NCT07157319 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–60 with symptomatic Haglund's syndrome who have failed at least six months of conservative treatment and do not have tendon rupture, severe systemic disease, active infection, Charcot joint, or peripheral vascular disease are the intended candidates.
✕Probably not a fit
Patients with Achilles tendon rupture or degeneration, uncontrolled diabetes, active osteomyelitis or other infections, Charcot joint, peripheral vascular disease, or those outside the 18–60 age range are unlikely to benefit from this procedure in this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective case series conducted at the Orthopedics and Traumatology department of Sohag University hospitals in Sohag, Egypt. Adults with symptomatic Haglund's syndrome refractory to six months of conservative treatment will undergo a dorsal closing-wedge calcaneal osteotomy (Zadek osteotomy) and be followed for short-term clinical, radiological, and functional outcomes. Patients with Achilles tendon rupture/degeneration, uncontrolled diabetes, active infection, Charcot joint, or peripheral vascular disease will be excluded. Outcomes will include pain, footwear comfort, function, and imaging measures of calcaneal anatomy.
Why it matters
Potential benefit: If successful, the procedure could reduce posterior heel pain, improve footwear comfort and activity, and restore function for patients with refractory Haglund's syndrome.
How similar studies have gone: Zadek osteotomy and similar calcaneal osteotomies have been reported in case series with favorable short-term outcomes, but high-quality comparative trials are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients over 18 years of age and less than 60 Yrs * All patients had at least six months of conservative treatment Exclusion Criteria: 1. patients below 18 years of age and more than 60 Yrs 2. patients of Haglund's syndrome with AT rupture or degeneration 3. uncontrolled diabetic patients with or without neuropathic joint destruction, 4. Infection such as osteomyelitis. 5. Charcot joint. 6. Peripheral vascular disease
Where it's running
-
Faculty of medicine, Sohag University
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: Mohamed Kamal Abd Alhakeem Mohamed Kamal Abd Alhakeem, Orthopedics resident, Sohag Un
- Email: mo.hakeem2020@gmail.com
- Phone: +201550529605
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Trauma registry at Sohag University Hospital
This study tests the creation of a trauma registry in the emergency department to collect data on injured adults admitted with polytrauma at Sohag University Hospital.
-
Prevalence of Myocardial Bridging and its relation to Coronary Plaques on MDCT
This study tests how common myocardial bridging is and whether it relates to coronary plaque in patients undergoing coronary CT angiography.
-
Septoplasty: see if it changes headache symptoms
This study tests whether septoplasty can change headache severity in adults with septal deviation and headache.
-
Predicting SLE Flares with Patient Reports and Machine Learning
Aims to test a low-cost, patient-reported outcome–based machine learning tool to see if it can detect lupus flares early and support care, especially in settings with limited resources.
-
Is geographic mismatch linked to short-term major heart problems after long drug-eluting stent placement?
This study checks whether geographic mismatch can predict short-term major adverse cardiovascular events after a long drug-eluting stent is placed in the coronary arteries.
-
Biomarkers to predict no-reflow after opening the heart’s artery in STEMI patients
This study tests whether immune-inflammatory and metabolic biomarkers can predict coronary no-reflow after primary PCI in adults with STEMI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.